Results for tag: "Gastrointestinal Agent"

The Gastrointestinal Agent market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. These agents are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and antibiotics. Other agents, such as probiotics, are also used to treat gastrointestinal disorders. The Gastrointestinal Agent market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, GlaxoSmithKline, Merck, AstraZeneca, and Novartis. Other companies, such as AbbVie, Allergan, and Takeda, also offer products in this market. Show Less Read more